# Andreas Haldimann

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/andreas-haldimann/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,242 |
| Field | Antibiotic Resistance in Bacteria |
| h-index | 18 |
| i10-index | 21 |
| Last Known Institution | Roche (Switzerland) |
| OpenAlex ID | https://openalex.org/A5023619053 |
| ORCID iD | 0009-0008-4822-4122 |
| Works | 27 |

## Researcher papers

- [Conditional-Replication, Integration, Excision, and Retrieval Plasmid-Host Systems for Gene Structure-Function Studies of Bacteria](https://scholariq.org/papers/conditional-replication-integration-excision-and-retrieval-plasmid-host-systems/)
- [Conditionally Replicative and Conjugative Plasmids CarryinglacZα for Cloning, Mutagenesis, and Allele Replacement in Bacteria](https://scholariq.org/papers/conditionally-replicative-and-conjugative-plasmids-carryinglacz-for-cloning/)
- [A novel antibiotic class targeting the lipopolysaccharide transporter](https://scholariq.org/papers/a-novel-antibiotic-class-targeting-the-lipopolysaccharide-transporter/)
- [Use of New Methods for Construction of Tightly Regulated Arabinose and Rhamnose Promoter Fusions in Studies of the <i>Escherichia coli</i> Phosphate Regulon](https://scholariq.org/papers/use-of-new-methods-for-construction-of-tightly-regulated-arabinose-and-rhamnose/)
- [Increased hydrophobic interactions of iclaprim with Staphylococcus aureus dihydrofolate reductase are responsible for the increase in affinity and antibacterial activity](https://scholariq.org/papers/increased-hydrophobic-interactions-of-iclaprim-with-staphylococcus-aureus/)
- [Activity of nacubactam (RG6080/OP0595) combinations against MBL-producing Enterobacteriaceae](https://scholariq.org/papers/activity-of-nacubactam-rg6080-op0595-combinations-against-mbl-producing/)
- [Transcriptional regulation of the Enterococcus faecium BM4147 vancomycin resistance gene cluster by the VanS-VanR two-component regulatory system in Escherichia coli K-12](https://scholariq.org/papers/transcriptional-regulation-of-the-enterococcus-faecium-bm4147-vancomycin/)
- [<i>In vivo</i> characterization of the type A and B vancomycin-resistant enterococci (VRE) VanRS two-component systems in <i>Escherichia coli</i> : A nonpathogenic model for studying the VRE signal transduction pathways](https://scholariq.org/papers/i-in-vivo-i-characterization-of-the-type-a-and-b-vancomycin-resistant/)
- [<i>Escherichia coli phnN</i> , Encoding Ribose 1,5-Bisphosphokinase Activity (Phosphoribosyl Diphosphate Forming): Dual Role in Phosphonate Degradation and NAD Biosynthesis Pathways](https://scholariq.org/papers/i-escherichia-coli-phnn-i-encoding-ribose-1-5-bisphosphokinase-activity/)
- [Altered recognition mutants of the response regulator PhoB: A new genetic strategy for studying protein–protein interactions](https://scholariq.org/papers/altered-recognition-mutants-of-the-response-regulator-phob-a-new-genetic/)
- [Mutations in two-component signaling systems drive experimental evolution of tigecycline and colistin resistance in <i>Acinetobacter baumannii</i>](https://scholariq.org/papers/mutations-in-two-component-signaling-systems-drive-experimental-evolution-of/)

## Researcher topics

- [Antibiotic Resistance in Bacteria](https://scholariq.org/topics/antibiotic-resistance-in-bacteria/)
- [Bacterial Genetics and Biotechnology](https://scholariq.org/topics/bacterial-genetics-and-biotechnology/)
- [Antimicrobial Resistance in Staphylococcus](https://scholariq.org/topics/antimicrobial-resistance-in-staphylococcus/)
- [Antibiotic Use and Resistance](https://scholariq.org/topics/antibiotic-use-and-resistance/)
- [Antibiotics Pharmacokinetics and Efficacy](https://scholariq.org/topics/antibiotics-pharmacokinetics-and-efficacy/)

## Researcher university

- [Roche (Switzerland)](https://scholariq.org/institutions/roche-switzerland/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
